Two Sigma Advisers »

Mersana Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $315k 41k 7.76

More positions owned by Two Sigma Advisers

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)
Meta Platforms Cl A (META)
Bank of America Corporation (BAC)
Mastercard Incorporated Cl A (MA)
Costco Wholesale Corporation (COST)
Lockheed Martin Corporation (LMT)
Intuitive Surgical Com New (ISRG)
Adobe Systems Incorporated (ADBE)
Charles Schwab Corporation (SCHW)

View all positions for Two Sigma Advisers

Top funds holding Mersana Therapeutics

Nextech Invest
Alamea Verwaltungs GmbH
Bain Capital Life Sciences Investors
Vanguard Group
Schonfeld Strategic Advisors
Rock Springs Capital Management
Acadian Asset Management
Silverarc Capital Management
683 Capital Management
BlackRock
Renaissance Technologies
Millennium Management
5AM Venture Management
Mackenzie Financial
AQR Capital Management

View all funds holding Mersana Therapeutics